The Patent Finder
US

Methods of Treating Hepatitis Delta Virus Infection with BETA-L-2'-Deoxy-NUCLEOSIDES

US 6,596,700 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Jul 22, 2011 on the fee record · High confidence

Second maintenance fee unpaid; grace period ended.

Held by Novartis AG
Filed May 29, 2001 as application 09/867,110 · Granted Jul 22, 2003
Base term, 20 years from filing
Today
Lapsed Jul 22, 2011
2001 2026
Clock starts
May 29, 2001
No longer in force
Jul 22, 2011
Granted
Jul 22, 2003
Term would have run to
May 29, 2021
base term after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
52
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

Its term would have run to May 29, 2021: its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 29, 2001, when this application, 09/867,110, was filedMay 29, 2021High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidlapsed Jul 22, 2011High confidence
Computed term endThe steps above, in orderJul 22, 2011High confidence

This family

US 6,596,700this patent
Jul 2011
Jul 2011
US 6,566,344Term ended
Aug 2019
Aug 2019
US 6,569,837Term ended
no later than Oct 2020
no later than Oct 2020
US 6,787,526Lapsed on the fee record
Sep 2012
Sep 2012
US 6,946,450Term ended
Aug 2019
Aug 2019
US 7,608,600In force
no later than Sep 2028
no later than Sep 2028
US 7,662,798Lapsed on the fee record
Feb 2022
Feb 2022
Application 11/005,440Abandoned
not computed
not computed
8 of 52 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 20, 2001
Reel 12033, frame 720
Sommadossi, Jean Pierre; Bryant, Martin L.Novirio Pharmaceuticals LimitedAssignment of Assignor's Interest
Sep 13, 2001
Reel 12151, frame 808
Sommadossi, Jean Pierre; Bryant, Martin L.Novirio Pharmaceuticals LimitedAssignment of Assignor's Interest
Aug 19, 2002
Reel 13193, frame 841
Novirio Pharmaceuticals LimitedIdenix Pharmaceuticals Inc.Change of Name
Feb 6, 2003
Reel 13718, frame 543
Novirio Pharmaceuticals LimitedIdenix Pharmaceuticals Inc.Certicate of Domestication Incorporation in Delaware
Jan 18, 2008
Reel 20385, frame 24
Idenix Pharmaceuticals, Inc.; Idenix (Cayman) LimitedNovartis AGAssignment of Assignor's Interest
Jun 25, 2009
Reel 22878, frame 155
Idenix Pharmaceuticals, Inc.Novartis AGCorrective Assignment to Remove Assignor the Assignor, Previously Recorded on Reel 020385 Frame 0024. Assignor(S) Hereby Confirms the Assignment.

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited